Technical Analysis for CSTL - Castle Biosciences, Inc.

Grade Last Price % Change Price Change
D 18.95 0.50% 0.10
CSTL closed up 0.5 percent on Monday, March 18, 2024, on 69 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.50%
Wide Bands Range Expansion 0.50%
Down 3 Days in a Row Weakness 0.50%
Down 4 Days in a Row Weakness 0.50%
Down 5 Days in a Row Weakness 0.50%
Narrow Range Bar Range Contraction -1.84%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 9 hours ago
Up 2% about 10 hours ago
Up 1% about 11 hours ago
60 Minute Opening Range Breakout about 12 hours ago
Fell Below Previous Day's Low about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Test Gene Expression Metastasis Dsw Uveal Melanoma

Is CSTL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.7
52 Week Low 9.2601
Average Volume 253,738
200-Day Moving Average 18.37
50-Day Moving Average 21.94
20-Day Moving Average 21.67
10-Day Moving Average 20.23
Average True Range 1.33
RSI (14) 37.50
ADX 28.74
+DI 14.70
-DI 31.93
Chandelier Exit (Long, 3 ATRs) 21.62
Chandelier Exit (Short, 3 ATRs) 21.40
Upper Bollinger Bands 26.32
Lower Bollinger Band 17.02
Percent B (%b) 0.21
BandWidth 42.91
MACD Line -0.99
MACD Signal Line -0.64
MACD Histogram -0.3565
Fundamentals Value
Market Cap 509.82 Million
Num Shares 26.9 Million
EPS -2.84
Price-to-Earnings (P/E) Ratio -6.67
Price-to-Sales 3.35
Price-to-Book 1.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.92
Resistance 3 (R3) 19.92 19.60 19.76
Resistance 2 (R2) 19.60 19.35 19.60 19.70
Resistance 1 (R1) 19.27 19.20 19.44 19.27 19.65
Pivot Point 18.95 18.95 19.03 18.95 18.95
Support 1 (S1) 18.62 18.70 18.79 18.62 18.24
Support 2 (S2) 18.30 18.55 18.30 18.19
Support 3 (S3) 17.97 18.30 18.13
Support 4 (S4) 17.97